HLN NYSE · Healthcare · FY 2025-12-31

Haleon plc

Back to NYSE
0.02.04.06.08.0ABVnot valid for this companyEPVfair 2.10buy ≤ 1.36EBVfair 3.42buy ≤ 2.56DBVfair 3.23buy ≤ 2.10price 7.41 GBP
0.02.75.38.010.7ABVnot valid for this companyEPVfair 2.79buy ≤ 1.81EBVfair 4.55buy ≤ 3.41DBVfair 4.30buy ≤ 2.79price 9.87 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in GBPUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Asset-Light Compounder
Confidence
●●● High · 3/4
Price
7.4109.870 GBPUSD *
Market cap
65.99B87.90B GBPUSD *
P / B
4.02
P / E
20.03
EPS
0.3700.493
DPS / yield
0.1430.190 (1.9%)
NAV / share
-1.025-1.365
Graham number
3.9195.219
Z'' score
4.29
Piotroski F
8 / 9
Beneish M
-2.57
ROIC vs WACC
8.2% vs 5.7%

* Listed in USD — the pipeline states price and all valuations in the filing currency GBP (fx 0.75 GBP/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.